Litcius/Paper detail

Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2

Roshan Kumar Roy, Uttam Sharma, Mishi Kaushal Wasson, Aklank Jain, Md. Imtaiyaz Hassan, Hridayesh Prakash

2021Frontiers in Immunology30 citationsDOIOpen Access PDF

Abstract

Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakEpigeneticsImmune systemVirologyImmunologyMedicineSars virusBiologyGeneticsOutbreakGeneInfectious disease (medical specialty)DiseasePathologyCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2 | Litcius